3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, T-Cell, Peripheral
1
Lymphoma
1
Interventions
Vincristine
7
Cyclophosphamide
7
10-propargyl-10-deazaaminopterin
7
Prednisone
6
Doxorubicin
6
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
5
romidepsin
3
belinostat
3
Gemcitabine
3
liposomal doxorubicin
2
duvelisib
1
Vitamin B 12
1
MLN 8237
1
Folic Acid
1
Etoposide
1
E7777 fusion protein
1
Decitabine
1
CHOP protocol
1
Brentuximab Vedotin
1
Bendamustine Hydrochloride
1
BAEC protocol
1
Alemtuzumab
1
1-dodecylpyridoxal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Lymphoma, T-Cell, Peripheral
×
CHOP protocol
×
Clear all
NCT00970385
2009-09-09
LTP
University Hospital, Grenoble
Phase 3
Completed
95 enrolled